Diffusion-weighted MR imaging allows monitoring the effect of combretastatin A4 phosphate on rabbit implanted VX2 tumor model: 12-Day dynamic results

European Journal of Radiology

Volumn 81, Issue 3, 2012, Pages 578-583

  Shao, Haibo ^a   Ni, Yicheng ^b   Dai, Xu ^a   Zhang, Jian ^c   Chen, Feng ^b   Fan, Guoguang ^a   Sun, Ziping ^d   Li, Yaming ^a   Zhou, Hongxu ^a   Xu, Ke ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Jiangsu Provincial Academy of Traditional Chinese Medicine   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Combretastatin A 4 phosphate; Diffusion magnetic resonance imaging; Experimental; Neoplasms; Rabbits; Vascular targeting

Indexed keywords

COMBRETASTATIN A4 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DRUG EFFECT; DRUG MONITORING; EDEMA; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; ISCHEMIA; NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; HINDLIMB; INFUSIONS, INTRAVENOUS; NEOPLASMS, EXPERIMENTAL; RABBITS; RANDOM ALLOCATION; STILBENES;

EID: 84856958890     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.03.009     Document Type: Article

References (19)

1. G.J. Rustin, S.M. Galbraith, and H. Anderson Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results J Clin Oncol 21 15 2003 2815 2822
2. D.W. Siemann, and M.R. Horsman Vascular targeted therapies in oncology Cell Tissue Res 335 1 2009 241 248
3. D.J. Chaplin, M.R. Horsman, and D.W. Siemann Current development status of small-molecule vascular disrupting agents Curr Opin Invest Drugs 7 6 2006 522 528
4. J.A. Vossen, M. Buijs, and I.R. Kamel Assessment of tumor response on MR imaging after locoregional therapy Tech Vasc Interv Radiol 9 3 2006 125 132
5. R. Sugita, K. Ito, N. Fujita, and S. Takahashi Diffusion-weighted MRI in abdominal oncology: clinical applications World J Gastroenterol 16 7 2010 832 836
6. H. Wang, M. Van de Putte, and F. Chen Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology Eur Radiol 18 7 2008 422 430
7. H. Wang, X. Sun, and F. Chen Treatment of rodent liver tumor with combretastatin A4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology Invest Radiol 44 1 2009 44 53
8. R.J. Maxwell, J. Wilson, and V.E. Prise Evaluation of the anti-vascular effects of combretastatin in rodent tumors by dynamic contrast enhanced MRI NMR Biomed 15 2 2002 89 98
9. V.E. Prise, D.J. Honess, M.R. Stratford, J. Wilson, and G.M. Tozer The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses Int J Oncol 21 4 2002 717 726
10. H.L. Anderson, J.T. Yap, M.P. Miller, A. Robbins, T. Jones, and P.M. Price Assessment of pharmacodynamic vascular response in a phase l trial of combretastatin A4 phosphate J Clin Oncol 21 15 2003 2823 2830
11. V. Vandecaveye, P. Dirix, and F. De Keyzer Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma Eur Radiol 20 7 2010 1703 1714
12. A.R. Padhani, G. Liu, and D.M. Koh Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2 2009 102 125
13. D.W. Siemann, E. Mercer, S. Lepler, and A.M. Rojiani Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy Int J Cancer 99 1 2002 1 6
14. A.M. Herneth, S. Guccione, and M. Bednarski Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization Eur J Radiol 45 3 2003 208 213
15. Z.X. Jiang, W.J. Peng, and W.T. Li Effect of b value on monitoring therapeutic response by diffusion-weighted imaging World J Gastroenterol 14 38 2008 5893 5899
16. D.C. Gadsby, A. Takeuchi, P. Artigas, and N. Reyes Review. Peering into an ATPase ion pump with single-channel recordings Philos Trans R Soc Lond B Biol Sci 364 1514 2009 229 238
17. G.M. Tozer, C. Kanthou, C.S. Parkins, and S.A. Hill The biology of the combretastatins as tumor vascular targeting agents Int J Exp Pathol 83 1 2002 21 38
18. G.J. Rustin, G. Shreeves, and P.D. Nathan A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer Br J Cancer 102 9 2010 1355 1360
19. H.C. Thoeny, F. De Keyzer, and F. Chen Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin A-4 phosphate after repeated administration Neoplasia 7 8 2005 779 787